No Data
No Data
Earnings Preview: CAPR to Report Financial Results Post-market on November 13
Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13
Express News | Capricor Therapeutics Files Prospectus Relates to Resale by Selling Stockholder of up to 2.8 Mln Shares of Common Stock -SEC Filing
Insider Stock Research: New Fortress Energy, Marvell, and More
Capricor Therapeutics Analyst Ratings
Retail Investors Account for 45% of Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Ownership, While Institutions Account for 14%
No Data
No Data
7122413 : Old filing
CSCHAN : Bro still can hold ?